Weight-loss drug cuts risk of heart attack, strokes: Novo Nordisk - World
COPENHAGEN: Danish pharma group Novo Nordisk’s obesity drug Wegovy cuts the risk of heart attacks and strokes by a...
Stay updated with breaking news from Simon Cork. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
COPENHAGEN: Danish pharma group Novo Nordisk’s obesity drug Wegovy cuts the risk of heart attacks and strokes by a...
Scientists said it was not clear precisely how the drug cut people’s risk of heart complications.
Trial suggests Wegovy cuts risk of cardiovascular event in overweight people with heart disease by a fifth.
Wegovy manufacturer says five-year study found drug reduced major cardiovascular events by 20% in overweight or obese people
From how well they work to side effects such as hair loss, here’s the skinny on new weight loss injections that work by blocking a hormone that normally reduces appetite